Accelerating the Development of Biomarkers for Drug Safety
Workshop Summary
-
- $16.99
-
- $16.99
Publisher Description
Biomarkers can be defined as indicators of any biologic state, and they are central to the future of medicine. As the cost of developing drugs has risen in recent years, reducing the number of new drugs approved for use, biomarker development may be a way to cut costs, enhance safety, and provide a more focused and rational pathway to drug development.
On October 24, 2008, the IOM's Forum on Drug Discovery, Development, and Translation held "Assessing and Accelerating Development of Biomarkers for Drug Safety," a one-day workshop, summarized in this volume, on the value of biomarkers in helping to determine drug safety during development.
GENRE
Professional & Technical
RELEASED
2009
July 20
LANGUAGE
EN
English
LENGTH
100
Pages
PUBLISHER
National Academies Press
SELLER
National Academy of Sciences
SIZE
834.6
KB
More Books Like This
Advancing Disease Modeling in Animal-Based Research in Support of Precision Medicine
2018
Principles of Biomedical Sciences and Industry
2022
Progress and Challenges in Precision Medicine
2016
The Role of the Study Director in Nonclinical Studies
2014
Toxicogenomic Technologies and Risk Assessment of Environmental Carcinogens
2005
Value Creation in the Pharmaceutical Industry
2016